Probiotec Limited Share Price

Equities

PBP

AU000000PBP7

Pharmaceuticals

Market Closed - Australian S.E. 11:40:45 26/04/2024 am IST 5-day change 1st Jan Change
2.83 AUD -0.35% Intraday chart for Probiotec Limited -0.35% -2.41%

Financials

Sales 2024 * 238M 156M 12.98B Sales 2025 * 253M 165M 13.76B Capitalization 230M 150M 12.53B
Net income 2024 * - Net income 2025 * - EV / Sales 2024 * 1.25 x
Net Debt 2024 * 68.26M 44.59M 3.72B Net Debt 2025 * 86.06M 56.22M 4.69B EV / Sales 2025 * 1.25 x
P/E ratio 2024 *
-
P/E ratio 2025 *
-
Employees -
Yield 2024 *
2.58%
Yield 2025 *
2.58%
Free-Float 68.09%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.35%
1 week-0.35%
Current month-2.41%
1 month-1.05%
6 months+12.75%
Current year-2.41%
More quotes
1 week
2.82
Extreme 2.82
2.89
1 month
2.79
Extreme 2.79
2.90
Current year
2.71
Extreme 2.71
2.94
1 year
2.14
Extreme 2.135
2.94
3 years
1.92
Extreme 1.915
2.94
5 years
1.50
Extreme 1.495
2.94
10 years
0.15
Extreme 0.15
2.94
More quotes
Managers TitleAgeSince
Chief Executive Officer - 27/10/27
Director of Finance/CFO - 01/02/01
Chief Operating Officer - -
Members of the board TitleAgeSince
Chief Executive Officer - 27/10/27
Chairman - 01/20/01
Director/Board Member - 01/21/01
More insiders
Date Price Change Volume
26/24/26 2.83 -0.35% 11,162
24/24/24 2.84 0.00% 59,827
23/24/23 2.84 -0.70% 55,744
22/24/22 2.86 +0.70% 110,601
19/24/19 2.84 -0.35% 84,109

Delayed Quote Australian S.E., April 26, 2024 at 11:40 am IST

More quotes
Probiotec Limited is an Australia-based manufacturer, packer and distributor of a range of prescription and over the counter (OTC) pharmaceuticals, complementary medicines, consumer health products, and fast-moving consumer goods (FMCG). The Company owns approximately six manufacturing facilities in Australia and distributes its products both domestically and internationally. It offers full-service contract manufacturing and packing. The Company manufactures products on behalf of a range of clients, including international pharmaceutical companies. The Company services blue-chip manufacturers, multinational FMCG companies, local manufacturers and brand custodians. All types of FMCG products are packed or handled, such as canned food, alcohol, tea and coffee, dairy and frozen foods, sauces and condiments, and bottled water. Its subsidiaries include Probiotec Pharmaceuticals Pty Ltd, Probiotec Pharma Pty Ltd, Multipack-LJM Pty Ltd, LJM (NSW) Pty Ltd and HH Packaging Pty Ltd.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
2.83 AUD
Average target price
3 AUD
Spread / Average Target
+6.01%
Consensus

Quarterly revenue - Rate of surprise